Loading clinical trials...
Loading clinical trials...
Bevacizumab Combined With Cisplatin Versus Cisplatin Monotherapy in Malignant Serous Effusions-A Prospective Randomized Controlled Study
Conditions
Interventions
Intracavity injection of bevacizumab 7.5mg/kg plus cisplatin 40mg/m2
cisplatin 40mg/m2 intracavity injection
Locations
1
China
Qingdao Central Hospital
Qingdao, Shandong, China
Start Date
July 1, 2025
Primary Completion Date
December 1, 2026
Completion Date
May 1, 2027
Last Updated
July 29, 2025
NCT06277024
NCT01291667
Lead Sponsor
Qingdao Central Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions